WuXi Clinical Revenue and Competitors
Estimated Revenue & Valuation
- WuXi Clinical's estimated annual revenue is currently $22.3M per year.
- WuXi Clinical's estimated revenue per employee is $201,000
Employee Data
- WuXi Clinical has 111 Employees.
- WuXi Clinical grew their employee count by -14% last year.
WuXi Clinical's People
| Name | Title | Email/Phone |
|---|
WuXi Clinical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is WuXi Clinical?
We are a CRO that nurtures long-term partnerships. For over 20-years our flexibility has seen us trusted by many of the industry's most pioneering innovators to help ensure their pipelines reach full potential. We are specialists in the design and implementation of global clinical trials. With offices in 20+ countries and clinical coverage in 60, we offer unparalleled access, and global expertise delivered only by experienced teams. WuXi Clinical was formed by the merging of capabilities in Research Point Global – a flexible US headquartered CRO that specializes in global clinical trials for small to mid-sized sized pharma customers – and WuXi CDS, China's largest and most capable CRO. Together, we are a global full-service CRO at the forefront of harnessing new opportunities between the USA and China.
keywords:N/A
N/A
Total Funding
111
Number of Employees
$22.3M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
WuXi Clinical News
WuXi Advanced Therapies, a unit of WuXi AppTec, is partnering with a ... which are largely consistent with our label or our clinical trials...
Icon Wuxi Clinical Development The Medical Affairs Company (TMAC), Syneos Health Inc., Ashfield Healthcare Communications, IQVIA Holdings ZEINCRO Group,...
SHANGHAI, April 25, 2022 /PRNewswire/ -- WuXi AppTec (stock code: 603259. ... 271 in phase II and 1,446 in phase I and pre-clinical stages.
Other Companies in Austin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.1M | 111 | 6% | $54.8M |
#2 | $28.1M | 111 | -7% | $65.3M |
#3 | $27.8M | 111 | -19% | N/A |
#4 | $30.5M | 111 | -20% | $45M |
#5 | $30M | 111 | -10% | N/A |